在健康志愿者中进行的纯口服哈米因单次上升剂量第一阶段研究
Jessica L Ables1,2,3, Leah Israel1, Olivia Wood3
1Department of Psychiatry, Depression and Anxiety Center for Discovery and Treatment, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
药品级哈米因化物 (HCl) 在低于2.7mg/kg的剂量下是安全的. 较高剂量可能会引起副作用和有限的精神活性,在健康成年人中建立安全性和效果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
- 神经科学是一个神经科学.
背景情况:
- 哈米因是阿雅华斯卡的成分,在药品级中具有未知的精神活性作用.
- 对于哈米因化 (HCl) 的副作用和人类的安全性,剂量反应关系尚未确定.
研究的目的:
- 为了确定口服药品级哈尔HCl的最大耐受剂量 (MTD),在健康的成年人中.
- 为了描述药品级Harmine HCl的安全性和耐受性.
- 确定任何口服剂量是否表现出精神活性作用.
主要方法:
- 第1期,开放标签,单次上升剂量试验.
- 18-55岁的健康成年人,没有先前的精神疾病.
- 随机单剂量为100,200,300或500毫克,使用连续重新评估方法损害HCl.
主要成果:
- 确定最大耐受剂量 (MTD) 在100至200毫克之间.
- 在接受>2.7 mg/kg的参与者中,90%发生了剂量限制性毒性.
- 常见的不良事件包括轻度至中度的胃肠道和神经效应.
结论:
- 口服的harmine HCl在剂量<2.7 mg/kg时是安全的,副作用最小.
- 剂量>2.7 mg/kg与吐,嗜睡和有限的精神活动有关.
- 这项研究系统地描述了制药对健康个体的精神活性影响.
更多相关视频
06:06Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
相关概念视频
Phase I Reactions: Hydrolytic Reactions
An important hydrolytic reaction is ester hydrolysis. Ester bonds, often found in prodrugs, are broken down, increasing the solubility of drugs like aspirin and lidocaine for more straightforward elimination. Amide hydrolysis is another critical reaction, targeting amide bonds prevalent...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Metabolism: Phase I Reactions
Phase I Oxidative Reactions: Overview
Preclinical Development: Overview
Phase II Reactions: Glucuronidation
